Treatment and rehabilitation of Long COVID: A scope of the literature. Update July 2024

Gary Austin Raine; Claire Louise Khouja; Helen Fulbright; Katy Sutcliffe; Amanda Jayne Sowden

Treatment and rehabilitation of Long COVID: A scope of the literature. Update July 2024

Gary Austin Raine, Claire Louise Khouja, Helen Fulbright, Katy Sutcliffe, Amanda Jayne Sowden

Centre for Reviews and Dissemination

Research output: Book/Report › Commissioned report

Abstract

We identified 19 randomised controlled trials published between March and June 2024 that were focused on Long COVID treatment or rehabilitation. Across our nine reports produced to date, we have identified and assessed 140 trials published between January 2022 and June 2024.
• Eight of the 19 trials focused on treating generalised or multiple symptoms of Long COVID. Four trials focused specifically on respiratory or cardiovascular function or physical fitness. Four other trials focused solely on treating persistent problems with the sense of smell or taste (olfactory/gustatory dysfunction) and three trials evaluated treatments for fatigue.
• Two trials were rated positively for 10 out of the 13 quality criteria that we assessed. The other 17 trials gained a positive rating for between four and nine criteria.

Original language	English
Place of Publication	London
Publisher	EPPI-Centre, Social Science Research Unit, UCL Institute of Education, University College London.
Commissioning body	NIHR Policy Research Programme
Number of pages	31
ISBN (Print)	978-1-911605-61-4
Publication status	Published - 9 Sept 2024

Bibliographical note

Access to Document

LC_treatment9_July24_GR_6thAug-090924-LO
© Copyright 2024. Authors of the systematic reviews on the EPPI Centre website (http://eppi.ioe.ac.uk/) hold the copyright for the text of their reviews. The EPPI Centre owns the copyright for all material on the website it has developed, including the contents of the databases, manuals, and keywording and data-extraction systems. The centre and authors give permission for users of the site to display and print the contents of the site for their own non-commercial use, providing that the materials are not modified, copyright and other proprietary notices contained in the materials are retained, and the source of the material is cited clearly following the citation details provided. Otherwise, users are not permitted to duplicate, reproduce, re-publish, distribute, or store material from this website without express written permission.
Final published version, 1.29 MBLicence: CC BY-NC

Cite this

@book{db42c9ba577940a284dc0fee80e055d5,

title = "Treatment and rehabilitation of Long COVID: A scope of the literature. Update July 2024",

abstract = "We identified 19 randomised controlled trials published between March and June 2024 that were focused on Long COVID treatment or rehabilitation. Across our nine reports produced to date, we have identified and assessed 140 trials published between January 2022 and June 2024.• Eight of the 19 trials focused on treating generalised or multiple symptoms of Long COVID. Four trials focused specifically on respiratory or cardiovascular function or physical fitness. Four other trials focused solely on treating persistent problems with the sense of smell or taste (olfactory/gustatory dysfunction) and three trials evaluated treatments for fatigue.• Two trials were rated positively for 10 out of the 13 quality criteria that we assessed. The other 17 trials gained a positive rating for between four and nine criteria.",

author = "Raine, {Gary Austin} and Khouja, {Claire Louise} and Helen Fulbright and Katy Sutcliffe and Sowden, {Amanda Jayne}",

year = "2024",

month = sep,

day = "9",

language = "English",

isbn = "978-1-911605-61-4",

publisher = "EPPI-Centre, Social Science Research Unit, UCL Institute of Education, University College London.",

}

TY - BOOK

T1 - Treatment and rehabilitation of Long COVID

T2 - A scope of the literature. Update July 2024

AU - Raine, Gary Austin

AU - Khouja, Claire Louise

AU - Fulbright, Helen

AU - Sutcliffe, Katy

AU - Sowden, Amanda Jayne

PY - 2024/9/9

Y1 - 2024/9/9

N2 - We identified 19 randomised controlled trials published between March and June 2024 that were focused on Long COVID treatment or rehabilitation. Across our nine reports produced to date, we have identified and assessed 140 trials published between January 2022 and June 2024.• Eight of the 19 trials focused on treating generalised or multiple symptoms of Long COVID. Four trials focused specifically on respiratory or cardiovascular function or physical fitness. Four other trials focused solely on treating persistent problems with the sense of smell or taste (olfactory/gustatory dysfunction) and three trials evaluated treatments for fatigue.• Two trials were rated positively for 10 out of the 13 quality criteria that we assessed. The other 17 trials gained a positive rating for between four and nine criteria.

AB - We identified 19 randomised controlled trials published between March and June 2024 that were focused on Long COVID treatment or rehabilitation. Across our nine reports produced to date, we have identified and assessed 140 trials published between January 2022 and June 2024.• Eight of the 19 trials focused on treating generalised or multiple symptoms of Long COVID. Four trials focused specifically on respiratory or cardiovascular function or physical fitness. Four other trials focused solely on treating persistent problems with the sense of smell or taste (olfactory/gustatory dysfunction) and three trials evaluated treatments for fatigue.• Two trials were rated positively for 10 out of the 13 quality criteria that we assessed. The other 17 trials gained a positive rating for between four and nine criteria.

M3 - Commissioned report

SN - 978-1-911605-61-4

BT - Treatment and rehabilitation of Long COVID

PB - EPPI-Centre, Social Science Research Unit, UCL Institute of Education, University College London.

CY - London

ER -